We found 8 mohs skin cancer surgeons who accept Blue Choice Bronze PPO 005 near Houston, TX.

Showing 1-8 of 8
Selecting one of the sort options will cause this page to reload and list providers by the selected sort order.
Dr. Ida Francesca Orengo, MD
Specializes in MOHS-Micrographic Surgery
2002 Holcombe
Houston, TX
 

Dr. Ida Orengo practices MOHS-micrographic surgery. Areas of expertise for Dr. Orengo include chemical peels, skin biopsy, and skin surgery. Blue Cross/Blue Shield, Blue Cross Blue Shield Bronze, and Blue Cross Blue Shield HMO are among the insurance carriers that Dr. Orengo honors. Before performing her residency at a hospital affiliated with Baylor College of Medicine, Dr. Orengo attended Baylor College of Medicine for medical school. She has received the distinction of Texas Super Doctors. She is affiliated with Texas Children's Hospital, Houston Methodist, and Michael E. DeBakey VA Medical Center - Main Facility. Dr. Orengo welcomes new patients.

Read more

Clinical interests: Chemical Peels, Skin Cancer, Laser Treatment, Mohs Surgery, Skin Biopsy, Scar Removal, Skin ... (Read more)

Dr. Paul Martin Friedman, MD
Specializes in Dermatopathology, MOHS-Micrographic Surgery
6400 Fannin; Suite 2720
Houston, TX
 

Dr. Paul Friedman is a Houston, TX physician who specializes in dermatopathology and MOHS-micrographic surgery. His average patient rating is 4.5 stars out of 5. Dr. Friedman's clinical interests include facial problems, rosacea, and acne. He accepts Blue Cross Blue Shield Bronze, Blue Cross Blue Shield Gold, and United Healthcare Choice, as well as other insurance carriers. He attended the University of Tennessee Health Science Center College of Medicine for medical school and subsequently trained at NYU Langone Medical Center for residency. Awards and/or distinctions Dr. Friedman has received include Texas Super Doctors; H Texas Magazine Listing of Top Doctors in Houston; and Who's Who in America. His professional affiliations include Texas Children's Hospital, Houston Methodist, and Memorial Hermann - Texas Medical Center (TMC). His practice is open to new patients.

Read more

Clinical interests: Sclerotherapy, Juvederm, Chemical Peels, Skin Cancer, YAG Laser Surgery, Facial Problems, Rosacea, ... (Read more)

Dr. Valencia Dorchelle Thomas, MD
Specializes in Dermatopathology, MOHS-Micrographic Surgery
6655 Travis Street; Suite 600
Houston, TX
 

Dr. Valencia Thomas' specialties are dermatopathology and MOHS-micrographic surgery. Dr. Thomas has a 5.0 out of 5 star average patient rating. She is affiliated with Memorial Hermann - Texas Medical Center (TMC), The University of Texas Medical School at Houston, and The University of Texas MD Anderson Cancer Center. She is an in-network provider for several insurance carriers, including Blue Cross Blue Shield Bronze, Amerigroup Star, and Blue Cross Blue Shield Gold. Dr. Thomas's education and training includes medical school at the University of Chicago, Pritzker School of Medicine and residency at Massachusetts General Hospital and a hospital affiliated with Harvard Medical School. Her distinctions include: Annual Faculty Teaching Award; Thomas B. Fitzpatrick Memorial Education Fund Off-Site Elective Award; and Women's Dermatologic Society.

Read more
Dr. Leonard Harry Goldberg, MD
Specializes in Dermatopathology, MOHS-Micrographic Surgery
6565 Fannin Street
Houston, TX
 

Dr. Leonard Goldberg is a dermatopathology and MOHS-micrographic surgery specialist. He graduated from the University of Pretoria School of Medicine. For his residency, Dr. Goldberg trained at Stanford University Medical Center and Chris Hani Baragwanath Hospital. Dr. Goldberg's areas of expertise include facial problems, eyelid surgery, and rosacea. His average patient rating is 5.0 stars out of 5. Blue Cross/Blue Shield, Workers' Compensation, and Blue Cross Blue Shield Bronze are among the insurance carriers that Dr. Goldberg takes. Dr. Goldberg has received the distinction of Texas Super Doctors. He is professionally affiliated with Texas Children's Hospital and Houston Methodist. New patients are welcome to contact his office for an appointment.

Read more

Clinical interests: Dermabrasion, Sclerotherapy, Contact Dermatitis, Juvederm, Chemical Peels, Skin Cancer, YAG Laser ... (Read more)

Dr. Mark A Price, MD
Specializes in MOHS-Micrographic Surgery
1213 Hermann Drive; Suite 650
Houston, TX
 

Dr. Mark Price is a physician who specializes in MOHS-micrographic surgery. Dr. Price (or staff) speaks the following foreign languages: Spanish and Vietnamese. In his practice, Dr. Price focuses on skin cancer. Dr. Price's hospital/clinic affiliations include Memorial Hermann Greater Heights Hospital and Park Plaza Hospital. His education and training includes medical school at Baylor College of Medicine and residency at a hospital affiliated with Baylor College of Medicine. On average, patients gave Dr. Price a rating of 4.5 stars out of 5. He honors Blue Cross Blue Shield Bronze, Blue Cross Blue Shield HMO, and Blue Cross Blue Shield Gold, as well as other insurance carriers. He has received the distinction of Texas Super Doctors.

Read more

Clinical interests: Skin Cancer

Dr. Ryan W Ahern, MD
Specializes in MOHS-Micrographic Surgery
1213 Hermann Drive; Suite 650
Houston, TX
 

Dr. Ryan Ahern is a mohs skin cancer surgeon in Houston, TX, Sugar Land, TX, and Cypress, TX. Dr. Ahern (or staff) is conversant in Spanish and Vietnamese. In his practice, he is particularly interested in skin cancer. Dr. Ahern is professionally affiliated with Memorial Hermann Greater Heights Hospital and Park Plaza Hospital. He attended medical school at Tulane University School of Medicine. Dr. Ahern's training includes residency programs at Shands HealthCare and a hospital affiliated with Tulane University. His patients gave him an average rating of 5.0 out of 5 stars. Blue Cross Blue Shield Bronze, Blue Cross Blue Shield HMO, and Blue Cross Blue Shield Gold are among the insurance carriers that Dr. Ahern takes. Dr. Ahern's distinctions include: Texas Rising Stars and Texas Super Doctors.

Read more

Clinical interests: Skin Cancer

Dr. Arash Kimyai-Asadi, MD
Specializes in Dermatopathology, MOHS-Micrographic Surgery
6565 Fannin Street
Houston, TX
 

Dr. Arash Kimyai-Asadi sees patients in Houston, TX. His medical specialties are dermatopathology and MOHS-micrographic surgery. Dr. Kimyai-Asadi's clinical interests include warts, contact dermatitis, and dermabrasion. He is an in-network provider for Blue Cross/Blue Shield, Blue Cross Blue Shield Bronze, and Blue Cross Blue Shield Gold, in addition to other insurance carriers. He graduated from Johns Hopkins University School of Medicine and then he performed his residency at a hospital affiliated with New York University (NYU). He is affiliated with Houston Methodist. Dr. Kimyai-Asadi is open to new patients.

Read more

Clinical interests: Warts, Dermabrasion, Contact Dermatitis, Cosmetic Surgery, Chemical Peels, Skin Cancer, Tattoo ... (Read more)

Specializes in MOHS-Micrographic Surgery
1401 Binz Street; Suite 200
Houston, TX
 

Dr. Payal Patel is a physician who specializes in MOHS-micrographic surgery. She honors Blue Cross Blue Shield Bronze, Blue Cross Blue Shield HMO, and Blue Cross Blue Shield Gold, as well as other insurance carriers. She attended medical school at the University of North Texas Health Science Center, Texas College of Osteopathic Medicine. Dr. Patel has received the following distinction: Texas Rising Stars. She is professionally affiliated with Memorial Hermann.

Read more

Conditions / Treatments

Gender

Insurance

New Patients

Reviews

Medicare Patient Age

Medicare Patient Conditions

Medicare Patient Ethnicity

Medicare Patient Insurance Eligibility

Additional Information

Distinctions

Foreign Language

Research

Online Communication

Patient Demographic

Practice Affiliation

Time Commitments

Certifications

Credentials

Fellowship

Medical School

Residency

Years Since Graduation

What is MOHS-Micrographic Surgery?

Mohs micrographic surgery is a surgical treatment for skin cancer that was developed by Dr. Frederick Mohs in the 1930’s. It is the most effective technique for removing the most common types of skin cancer. For the two most common types of skin cancer, basal cell carcinoma and squamous cell carcinoma, Mohs has a 98-99% cure rate. The remarkable thing about Mohs is that it manages to be extremely good at removing all of the cancer cells while at the same time leaving behind most of the healthy tissue, so there is a smaller wound. This makes the procedure safer, speeds up the the recovery time, and minimizes scarring.

During Mohs surgery, skin around the cancer site is mapped out and removed in thin layers. Then each layer is examined under a microscope for cancer cells, while the surgery is in progress. If cancer cells are detected, the surgery continues and another layer is removed. If the skin is clear, the surgery can be stopped. This eliminates the guesswork for surgeons. There is no need to estimate the borders or roots of the cancer and no need to remove a margin of healthy tissue to ensure that all of the cancer is removed.

Even though Mohs has a high cure rate, is safer than other treatments, and takes less tissue, not every skin cancer is treated with Mohs. First, Mohs takes quite a bit longer than traditional surgery because each layer of skin must be carefully cut, prepped, and examined. It is also more expensive and may not always be covered by insurance. In addition, for smaller or less aggressive cancers that are easier to treat, the cure rate for non-Mohs treatments is close to that of Mohs; thus, the extra time and cost of Mohs might not be justified. Other kinds of skin cancer, such as melanoma, are hard to see under a microscope. Since melanoma is so dangerous, Mohs has traditionally not been used to treat it, as there is too much risk for missed cancer cells being left behind in the body. However, recent developments in stains (which make cancer cells more visible under a microscope) may change the role of Mohs in melanoma treatment.

Mohs microsurgery has changed the way doctors treat skin cancer in the past 80 years, and it continues to gain in popularity as it increases the effectiveness and safety of skin cancer treatment.
Selecting a checkbox option will refresh the page.